These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 27592131)

  • 41. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
    Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
    Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
    Yang X; Shi X; Ji J; Zhai G
    Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PEGylated pH-Responsive Liposomes for Enhancing the Intracellular Uptake and Cytotoxicity of Paclitaxel in MCF-7 Breast Cancer Cells.
    Nijhawan HP; Shyamsundar P; Prabhakar B; Yadav KS
    AAPS PharmSciTech; 2024 Sep; 25(7):216. PubMed ID: 39289249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TAT modified and lipid - PEI hybrid nanoparticles for co-delivery of docetaxel and pDNA.
    Dong S; Zhou X; Yang J
    Biomed Pharmacother; 2016 Dec; 84():954-961. PubMed ID: 27764758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
    Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
    Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.
    Sahu PK; Mishra DK; Jain N; Rajoriya V; Jain AK
    Drug Dev Ind Pharm; 2015 Apr; 41(4):640-9. PubMed ID: 24564799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel.
    Wang B; Lv L; Wang Z; Jiang Y; Lv W; Liu X; Wang Z; Zhao Y; Xin H; Xu Q
    Sci Rep; 2015 Nov; 5():16589. PubMed ID: 26567528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
    Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
    Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice.
    Zou Y; Song Y; Yang W; Meng F; Liu H; Zhong Z
    J Control Release; 2014 Nov; 193():154-61. PubMed ID: 24852094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel.
    Emami J; Rezazadeh M; Hasanzadeh F; Sadeghi H; Mostafavi A; Minaiyan M; Rostami M; Davies N
    Int J Biol Macromol; 2015 Sep; 80():29-40. PubMed ID: 26093319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.
    Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Chen D
    J Drug Target; 2015 May; 23(4):311-22. PubMed ID: 25539074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH; Lu Q; Xie J; Fang C; Chen HZ
    Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
    Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
    Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model.
    Zhuang YG; Xu B; Huang F; Wu JJ; Chen S
    Pharmazie; 2012 Nov; 67(11):925-9. PubMed ID: 23210242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
    Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
    Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
    Rosière R; Van Woensel M; Gelbcke M; Mathieu V; Hecq J; Mathivet T; Vermeersch M; Van Antwerpen P; Amighi K; Wauthoz N
    Mol Pharm; 2018 Mar; 15(3):899-910. PubMed ID: 29341619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition.
    Meng L; Xia X; Yang Y; Ye J; Dong W; Ma P; Jin Y; Liu Y
    Int J Pharm; 2016 Nov; 513(1-2):8-16. PubMed ID: 27596118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.